全文获取类型
收费全文 | 513篇 |
免费 | 29篇 |
国内免费 | 1篇 |
专业分类
财政金融 | 22篇 |
工业经济 | 17篇 |
计划管理 | 128篇 |
经济学 | 232篇 |
综合类 | 40篇 |
运输经济 | 3篇 |
旅游经济 | 8篇 |
贸易经济 | 30篇 |
农业经济 | 42篇 |
经济概况 | 21篇 |
出版年
2023年 | 11篇 |
2022年 | 5篇 |
2021年 | 14篇 |
2020年 | 38篇 |
2019年 | 22篇 |
2018年 | 25篇 |
2017年 | 37篇 |
2016年 | 22篇 |
2015年 | 25篇 |
2014年 | 33篇 |
2013年 | 124篇 |
2012年 | 23篇 |
2011年 | 43篇 |
2010年 | 34篇 |
2009年 | 12篇 |
2008年 | 19篇 |
2007年 | 7篇 |
2006年 | 11篇 |
2005年 | 6篇 |
2004年 | 4篇 |
2003年 | 8篇 |
2002年 | 2篇 |
2001年 | 8篇 |
2000年 | 3篇 |
1999年 | 5篇 |
1996年 | 1篇 |
1990年 | 1篇 |
排序方式: 共有543条查询结果,搜索用时 15 毫秒
31.
目前我国医疗水平趋于日益提高的状态,与此同时社会广大群体也逐渐意识到疾控工作的重要性,对疾控工作的重视度越来越大。疫苗,区别于一般的药品,是一种特殊的商品,由于其特殊性,在其采购、使用等任何一个环节出现问题都将会产生不可估量的严重后果,为此国务院设立了专门的条例(《疫苗流通和预防接种管理条例》)来对疫苗的管理进行规范。在对疫苗进行管理的过程中,各级疾控中心在其中占据了非常重要的角色,其是疫苗流通过程中重要的组成部分,在疫苗管理中有非常重要的作用。本文分析了疾控中心疫苗管理的基本情况以及疫苗管理中所存在的问题,并结合自己的工作经验,针对所存在的问题总结阐述了完善措施,以此来提高疾控中心疫苗财务管理的水平。 相似文献
32.
浅谈高等级公路沥青路面病害与养护 总被引:1,自引:0,他引:1
基于高等级公路的沥青路面早期病害的特征与成因,探讨了如何选择相适应的养护处治对策。 相似文献
33.
34.
Angus Macdonald 《Scandinavian actuarial journal》2013,2013(4):279-313
We describe briefly a model of Huntington's disease (HD), a highly penetrant, dominantly inherited, fatal neurological disorder. Although it is a single-gene disorder, mutations are variable in their effects, depending on the number of times that the CAG trinucleotide is repeated in a certain region of the HD gene. The model covers: (a) rates of onset, depending on CAG repeat length as well as age; (b) post-onset rates of mortality; and (c) the distribution of CAG repeat lengths in the population. Using these, we study the critical illness and life insurance markets. We calculate premiums based on genetic test results that disclose the CAG repeat length, or more simply on a family history of HD. These vary widely with age and policy term; some are exceptionally high, but in a large number of cases cover could be offered within normal underwriting limits. We then consider the possible costs of adverse selection, in terms of increased premiums, under various possible moratoria on the use of genetic information, including family history. These are uniformly very small, because of the rarity of HD, but do show that the costs would be much larger in relative terms if family history could not be used in underwriting. We point out some difficulties involved in applying a moratorium that recognises simply a dichotomy between ‘carriers’ and ‘non-carriers’ of any mutation in a gene when these mutations are, in fact, very variable in their effects. These complexities suggest that restrictions on the disclosure, rather than on the use, of genetic information, if it became established as a principle, could deprive insurers of information needed for risk management even if not used in underwriting. 相似文献
35.
《Journal of medical economics》2013,16(1):71-79
SummaryHeart failure (HF) is a serious public health problem worldwide. It has a high prevalence, affects mainly the elderly and causes high mortality or disability with high economic costs. The aim of the present study was to calculate the number of admissions for HF, the total in-hospital stay, the mean length of in-hospital stay and the in-hospital costs due to HF in Belgium.Retrospective analysis of data from the national hospital registration system provided the following results. In 2001, there were 19,398 admissions with HF as a primary diagnosis, with a total in-hospital stay of 286,938 days. The mean in-hospital stay for HF was 14.8 days. The total in-hospital cost of HF as a primary diagnosis was € 94,113,827, representing 1.8% of the total hospital expenditure.The limitations of this study are its mere focus on admissions and their characteristics in 2001, and the use of a retrospective analysis. Nevertheless, it led to the conclusion that HF was responsible for a significant number of in-hospital days, with a significant impact on healthcare costs in Belgium. 相似文献
36.
《Journal of medical economics》2013,16(3):428-437
AbstractObjective:This study assessed the long-term cost effectiveness of rosuvastatin therapy compared with placebo in reducing the incidence of major cardiovascular (CVD) events and mortality.Methods:A probabilistic Monte Carlo simulation model estimated long-term cost effectiveness of rosuvastatin therapy (20?mg daily) for the prevention of CVD mortality and morbidity. The model included three stages: (1) CVD prevention simulating the 4 years of the JUPITER trial, (2) initial CVD prevention beyond the trial, and (3) subsequent CVD event prevention. A US payer perspective was assessed reflecting direct medical costs, and up to a lifetime horizon. Sensitivity analyses tested the robustness of the model estimates.Results:For a hypothetical cohort of 100,000 patients at moderate and high risk of CVD events based on Framingham risk of ≥10%, estimated quality-adjusted life-years (QALYs) gained with rosuvastatin therapy compared with placebo was 33,480 over a lifetime horizon, and 25,380 and 9916 over 20-year and 10-year horizons, respectively. Approximately 12,073 events were avoided over the lifetime; 6,146 non-fatal MIs, 2905 non-fatal strokes, and 4030 CVD deaths avoided. Estimated incremental cost-effectiveness ratio (ICER) for cost per QALY was $7062 (lifetime), $10,743 (20-year horizon), and $44,466 (10-year horizon). For a hypothetical cohort similar to the overall JUPITER population, the cost per QALY ICER was $11,025 for the lifetime and $60,112 for a 10-year horizon.Limitations:The cost-effectiveness comparison of rosuvastatin 20?mg was against no active treatment (as opposed to an alternative statin) due to lack of comparative cardiovascular morbidity and mortality risk reduction data for other statins in a population similar to the JUPITER trial population. The analysis was conducted from the payer perspective and lack of inclusion of indirect costs limit interpretability of results from a societal perspective.Conclusions:Treatment with rosuvastatin 20?mg daily, is a cost-effective treatment alternative to no treatment in patients at a higher risk (Framingham risk ≥10%) of CVD. 相似文献
37.
城市的发展有其特定的内在规律性,其产生、发展、消亡的各个过程都是作为一个有机体变化更新的特定阶段。集聚效应和扩散效应是经济中心城市的两个主要功能。两者不同的机理分别产生"城市病"问题和内城问题。在城市化发展的过程中,集聚效应要先于扩散效应发生,因此内城问题往往产生于城市化后期。在城市的发展进程中,内城问题在表现特征上有着一些与"城市病"问题截然不同的方面,有其特殊的解决对策。 相似文献
38.
《Journal of medical economics》2013,16(1-4):85-105
SummaryRecent advances in HIV antiretroviral therapy together with limited budgets have forced payers to look for evidence that new combinations provide good value for money. Using a public financing perspective, two Markov models are employed to evaluate the first-year outcomes and costs and the long-term cost-effectiveness of adding nevirapine (NVP) to dual combination therapy with zidovudine (ZDV) and didanosine (ddI) in the United Kingdom.First-year medical care savings are estimated to be £2,122 (103.8% of NVP cost). In the longer term, NVP/ZDV/ddI therapy yields £6,186 per life year saved (costs discounted at 6%). The model is moderately sensitive only to duration of therapy effects and the therapy initiation time. These model estimates suggest that policy makers may expect to observe superior initial health outcomes and substantial medical cost savings during the first year of therapy, as well as acceptable long-term cost-effectiveness, when NVP/ZDV/ddI is used in place of dual therapy. 相似文献
39.
《Journal of medical economics》2013,16(4):704-711
AbstractObjective:Asthma is one of the most common childhood illnesses and accounts for a substantial amount of pediatric emergency department visits. Historically, acute exacerbations are treated with a beta agonist via nebulizer therapy (NEB). However, with the advent of the spacer, the medication can be delivered via a metered dose inhaler (MDI?+?S) with the same efficacy for mild-to-moderate asthma exacerbations. To date, no study has been done to evaluate emergency department (ED) length of stay (LOS) and opportunity cost between nebulized vs MDI?+?S. The objective of this study was to compare ED LOS and associated opportunity cost among children who present with a mild asthma exacerbation according to the delivery mode of albuterol: MDI?+?S vs NEB.Methods:A structured, retrospective cross-sectional study was conducted. Medical records were reviewed from children aged 1–18 years treated at an urban pediatric ED from July 2007 to June 2008 with a discharge diagnosis International Classification of Disease-9 of asthma. Length of stay was defined: time from initial triage until the time of the guardian signature on the discharge instructions. An operational definition was used to define a mild asthma exacerbation; those patients requiring only one standard weight based albuterol treatment. Emergency department throughput time points, demographic data, treatment course, and delivery method of albuterol were recorded.Results:Three hundred and four patients were analyzed: 94 in the MDI?+?S group and 209 in the NEB group. Mean age in years for the MDI?+?S group was 9.57 vs 5.07 for the NEB group (p?<?0.001). The percentage of patients that received oral corticosteroids was 39.4% in the MDI?+?S group vs 61.7% in the NEB group (p?<?0.001). There was no difference between groups in: race, insurance status, gender, or chest radiographs. The mean ED LOS for patients in the MDI?+?S group was 170 minutes compared to 205 minutes in the NEB group. On average, there was a 25.1 minute time savings per patient in ED treatment time (p?<?0.001; 95% CI?=?3.8–31.7). Significant predictors of outcome for treatment time were chest radiograph, steroids, and treatment mode. Opportunity cost analysis estimated a potential cost savings of $213,532 annually using MDI?+?S vs NEB.Conclusion:In mild asthma exacerbations, administering albuterol via MDI?+?S decreases ED treatment time when compared to administering nebulized albuterol. A metered dose inhaler with spacer utilization may enhance opportunity cost savings and decrease the left without being seen population with improved throughput.Limitations:The key limitations of this study include its retrospective design, the proxy non-standard definition of mild asthma exacerbation, and the opportunity cost calculation, which may over-estimate the value of ED time saved based on ED volume. 相似文献
40.
史敏 《安徽工业大学学报(社会科学版)》2001,18(4):73-74
以疾病为题材的文学作品揭示了文学与疾病的种种联系,它们把疾病组合进个人-疾病-社会这个特殊的三角形中。从心理学角度看,对读者可起到交流和治疗作用;从接受美学角度看,可成为健康人的学习资料和生活指南。 相似文献